Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15133317 | 1.00 | LMNA (0.33) | LMNATSHRALDH1A1TDP1L3MBTL1 | |
| SCHEMBL2481029 | 1.00 | LMNA (0.33) | LMNATSHRALDH1A1TDP1L3MBTL1 | |
| SCHEMBL14887480 | 0.83 | TSHR (0.46) | LMNATSHRTDP1 | |
| SCHEMBL16579815 | 0.82 | — | — | |
| SCHEMBL6422381 | 0.82 | — | — | |
| SCHEMBL12774646 | 0.79 | THRB (0.48) | LMNAALDH1A1 | |
| SCHEMBL1076490 | 0.78 | TSHR (0.33) | LMNATSHRALDH1A1TDP1 | |
| SCHEMBL12295744 | 0.77 | PRKCA (0.31) | — | |
| SCHEMBL1104257 | 0.73 | SLC22A6 (0.42) | LMNATDP1 | |
| SCHEMBL15704525 | 0.72 | TSHR (0.40) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9867767-B2 | Use of glucosylglycerol | BITOP AG (DE) | 2018-01-16 | — | — | US | disclosed |
| US-20170189435-A1 | COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | BITOP AG (DE) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170189435-A1 | COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | ENPP3, UGCG, ENPP1 | LMNA 3088/4885TSHR 2572/4885ALDH1A1 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.